Bachmann–Bupp syndrome and treatment
Open Access
- 19 July 2023
- journal article
- review article
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 66 (4) , 445-455
Abstract
Bachmann–Bupp syndrome (BABS) is a neurodevelopmental disorder characterized by developmental delay, hypotonia, and varying forms of non‐congenital alopecia. The condition is caused by 3′‐end mutations of the ornithine decarboxylase 1 (ODC1) gene, which produce carboxy (C)‐terminally truncated variants of ODC, a pyridoxal 5′‐phosphate‐dependent enzyme. C‐terminal truncation of ODC prevents its ubiquitin‐independent proteasomal degradation and leads to cellular accumulation of ODC enzyme that remains catalytically active. ODC is the first rate‐limiting enzyme that converts ornithine to putrescine in the polyamine pathway. Polyamines (putrescine, spermidine, spermine) are aliphatic molecules found in all forms of life and are important during embryogenesis, organogenesis, and tumorigenesis. BABS is an ultra‐rare condition with few reported cases, but it serves as a convincing example for drug repurposing therapy. α‐Difluoromethylornithine (DFMO, also known as eflornithine) is an ODC inhibitor with a strong safety profile in pediatric use for neuroblastoma and other cancers as well as West African sleeping sickness (trypanosomiasis). Patients with BABS have been treated with DFMO and have shown improvement in hair growth, muscle tone, and development.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD110500)
This publication has 103 references indexed in Scilit:
- Polyamine Transport Systems in Mammalian Cells and Tissues2011
- The Role of Polyamines in Supporting Growth of Mammalian Cells Is Mediated through Their Requirement for Translation Initiation and ElongationJournal of Biological Chemistry, 2010
- The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplificationInternational Journal of Cancer, 2009
- Polyamine catabolism and diseaseBiochemical Journal, 2009
- Mammalian polyamine metabolism and functionIUBMB Life, 2009
- Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastomaMolecular Cancer Therapeutics, 2009
- Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trialThe Lancet, 2009
- Hypusine-containing protein eIF5A promotes translation elongationNature, 2009
- Ornithine Decarboxylase Inhibition by α-Difluoromethylornithine Activates Opposing Signaling Pathways via Phosphorylation of Both Akt/Protein Kinase B and p27Kip1 in NeuroblastomaCancer Research, 2008
- Identification and Characterization of a Diamine Exporter in Colon Epithelial CellsJournal of Biological Chemistry, 2008